NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Samsung Pharm (KO: 001360)

 
001360 Technical Analysis
4
As on 28th Jan 2026 001360 STOCK Price closed @ 1676.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1579.85 & Strong Buy for SHORT-TERM with Stoploss of 1526.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

001360STOCK Price

Open 1612.00 Change Price %
High 1733.00 1 Day 67.00 4.16
Low 1612.00 1 Week 140.00 9.11
Close 1676.00 1 Month -176.00 -9.50
Volume 2601243 1 Year 95.00 6.01
52 Week High 1977.00 | 52 Week Low 1343.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
008600 378.00 -12.90%
008600 378.00 -12.90%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
071670 10060.00 70.51%
071670 10060.00 70.51%
168490 159.00 29.27%
168490 159.00 29.27%
012320 67200.00 21.52%
012320 67200.00 21.52%
152550 383.00 19.69%
152550 383.00 19.69%
 
KO Korea Top Losers Stocks
001140 14.00 -83.53%
001140 14.00 -83.53%
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
 
 
001360
Daily Charts
001360
Intraday Charts
Whats New @
Bazaartrend
001360
Free Analysis
 
001360 Important Levels Intraday
RESISTANCE1909.17
RESISTANCE1834.39
RESISTANCE1788.17
RESISTANCE1741.95
SUPPORT1610.06
SUPPORT1563.83
SUPPORT1517.61
SUPPORT1442.83
 
001360 Forecast January 2026
4th UP Forecast2171.24
3rd UP Forecast2012.41
2nd UP Forecast1914.24
1st UP Forecast1816.07
1st DOWN Forecast1535.94
2nd DOWN Forecast1437.76
3rd DOWN Forecast1339.59
4th DOWN Forecast1180.76
 
001360 Weekly Forecast
4th UP Forecast2055.62
3rd UP Forecast1933.87
2nd UP Forecast1858.62
1st UP Forecast1783.37
1st DOWN Forecast1568.64
2nd DOWN Forecast1493.38
3rd DOWN Forecast1418.13
4th DOWN Forecast1296.38
 
001360 Forecast2026
4th UP Forecast3510.5
3rd UP Forecast2922.17
2nd UP Forecast2558.5
1st UP Forecast2194.84
1st DOWN Forecast1157.16
2nd DOWN Forecast793.5
3rd DOWN Forecast429.83
4th DOWN Forecast-158.5
 
 
001360 Other Details
Segment EQ
Market Capital 404735426560.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
001360 Address
001360
 
001360 Latest News
 
Your Comments and Response on Samsung Pharm
 
001360 Business Profile
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceuticals and cosmetics in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as vitamins and energy drinks, and other processed foods. In addition, it offers skin care, mask, and patch care products. The company was founded in 1929 and is headquartered in Hwaseong, South Korea. Address: 35 Jeyakgongdan 2-gil, Hwaseong, South Korea, 445-746
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service